[1]. Cross DA, et al. AZD9291, an irreversible EGFR TKI, overcomes T790Mmediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014 Sep;4(9):1046-61.
[2]. Finlay MR, et al. Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistancemutations that spares the wild type form of the receptor. J Med Chem. 2014 Oct 23;57(20):8249-67.
1401791573(上海经销商,江苏,河南,湖北,内蒙古,新疆,西藏,香港,台湾)
3610331285(上海终端,浙江,湖南,重庆,安徽,甘肃,山西,宁夏,青海)
1419168828(北京,天津,河北,山东,陕西,辽宁,吉林,黑龙江)
3227045923(广东,福建,江西,四川,云南,贵州,广西,海南,澳门)